Nirmal Bang Institutional Equities

Rediff.com » News » Nirmal Bang Institutional Equities

News for Nirmal Bang Institutional Equities

Business

Q3 result preview: US, India to aid revenue growth for Pharma Inc

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for......

Auto industry Q2 preview: Product mix, commodity tailwinds to aid margins

Automobile manufacturers are likely to report strong numbers for the September quarter of Financial Year 2023-24 (Q2 FY24), riding on growth across segments and offset by a marginal drop in overall......

After strong run, retail demand feels the fatigue

The retail industry witnessed robust top-line growth for the greater part of the previous financial year, but demand has started to show signs of fatigue seen in the January-March quarter (fourth......

Should you invest in IT stocks? Here's what experts say

An aggressive rate hike by the US Fed and the possibility of a recession can trigger a slide in these stocks, which will be a good opportunity to buy from a long-term perspective. Puneet Wadhwa......

Gold glitters but Muthoot, Manappuram may stay pale

Despite gold prices hitting record highs, analysts aren't gung-ho about the outlook for gold financiers Muthoot Finance and Manappuram Finance. This, they said, was due to intense competition from......

Rediff News

Nirmal Bang Institutional Equities

News for Nirmal Bang Institutional Equities

Q3 result preview: US, India to aid revenue growth for Pharma Inc

Auto industry Q2 preview: Product mix, commodity tailwinds to aid margins

After strong run, retail demand feels the fatigue

Should you invest in IT stocks? Here's what experts say

Gold glitters but Muthoot, Manappuram may stay pale

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS